.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
While prophylactic factor replacement and non-factor therapies have transformed the management of bleeding disorders, significant haemophilia treatment unmet needs remain a reality for many patients. Recent data from the Global Adelphi Disease Specific Programme Database highlight that clinical outcomes in real-world settings often fall short of optimal benchmarks. Consequently, many individuals living with haemophilia (PwH) continue to face physical and humanistic challenges that impact their daily lives.
The cross-sectional survey involved 283 physicians and over 2,200 patients across multiple countries between 2023 and 2024. Interestingly, while 94% of patients demonstrated high compliance with their prescribed prophylaxis, clinical stability remained elusive for more than half of the cohort. Specifically, 57% of patients reported at least one bleeding episode annually. Furthermore, joint problems affected nearly 49% of the population, indicating that current regimens may not sufficiently protect musculoskeletal health.
Physicians expressed notable dissatisfaction with current prophylactic options for 56% of patients with haemophilia A and 59% of those with haemophilia B. Their primary concerns centered on administration methods, dosing schedules, and overall efficacy. Additionally, patients on all types of prophylaxis reported impairments in their health-related quality of life (HRQoL). These findings suggest that haemophilia treatment unmet needs extend beyond simple bleed counts to include lifestyle priorities and physical independence.
The study concludes that current treatment paradigms frequently fail to align with the lifestyle requirements of patients. Many individuals still experience limitations in productivity and daily activities. Therefore, a more patient-centred approach is essential to balance clinical effectiveness with personal goals. Clinicians should prioritize regular joint health assessments and discuss evolving therapy options to better address the persistent burden of the disease.
The most significant unmet needs include persistent joint problems, breakthrough bleeding episodes despite high compliance, and overall dissatisfaction with current dosing schedules and administration methods.
Despite being on prophylaxis, many patients report limitations in physical independence, reduced productivity at work or school, and ongoing chronic pain related to joint damage.
Physicians often cite concerns regarding the complexity of dosing schedules, the burden of administration, and the inadequate prevention of long-term joint complications as reasons for dissatisfaction.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A global survey reveals that despite high treatment compliance, many haemophilia patients still suffer from joint issues and frequent bleeding episodes....
3 months ago
A new study reveals that lipid-related metabolic dysregulation, marked by elevated TG/HDL-C ratio and glymphatic changes, independently impacts survival in idiopathic normal pressure hydrocephalus.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
A meta-analysis of 13 propensity score-matched studies shows ViV-TAVR delivers lower early mortality and reduced bleeding compared to redo-SAVR for degenerated bioprosthetic aortic valves, though long-term hemodynamics warrant careful anatomical and patient-centered evaluation.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
The All-India Food Processors' Association has approached the Supreme Court to oppose FSSAI's proposed per-100g benchmark for front-of-pack warning labels, advocating instead for a per-serving threshold. We explore the regulatory showdown, nutritional evidence, and implications for clinical lifestyle counseling.
Today
